Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer.

Önder, Cansu E; Ziegler, Teresa J; Becker, Ronja; Brucker, Sara Y; Hartkopf, Andreas D; Engler, Tobias; Koch, André

Önder, Cansu E; Ziegler, Teresa J; Becker, Ronja; Brucker, Sara Y; Hartkopf, Andreas D; Engler, Tobias; Koch, André.

Afiliação

Önder CE; Research Institute for Women's Health, University of Tübingen, 72076 Tübingen, Germany.
Ziegler TJ; Research Institute for Women's Health, University of Tübingen, 72076 Tübingen, Germany.
Becker R; Research Institute for Women's Health, University of Tübingen, 72076 Tübingen, Germany.
Brucker SY; Research Institute for Women's Health, University of Tübingen, 72076 Tübingen, Germany.
Hartkopf AD; Department of Women's Health, University of Tübingen, 72076 Tübingen, Germany.
Engler T; Department of Women's Health, University of Tübingen, 72076 Tübingen, Germany.
Koch A; Department of Women's Health, University of Tübingen, 72076 Tübingen, Germany.

Cancers (Basel) ; 15(14)2023 Jul 13.

Article em En | MEDLINE | ID: mdl-37509265

Palavras-chave

ascites; breast cancer; cancer biology; drug response; metastasis; organoid culture; patient-derived organoids; personalized medicine; pleural effusion

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google